Nonalcoholic Steatohepatitis Clinical Trial Pipeline Insights | 100+ Key Companies Investigating Their Lead Candidates to Improve the Treatment Space | medgadget.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medgadget.com Daily Mail and Mail on Sunday newspapers.
On December 28, 2023, the Board of Directors of Applied Therapeutics, Inc. appointed Constantine Chinoporos as the Company?s Chief Operating Officer and Chief Business Officer, effective as of.
BOS-580 treatment improved markers of glycemic control and reduced liver steatosis across diabetic sub-populations with phenotypic NASHAdditional data support the continued development of BOS-580 once-monthly dosingCAMBRIDGE, Mass. (BUSINESS WIRE) Boston Pharmaceuticals, a clinical-stage biopharmaceutical company.